Trial intelligence / Profile preview

Oral Contraceptives for Retained Pregnancy Products

NCT03230825Unknown

Sponsor
Meir Medical Center
Start
Sep 2017
Primary completion
Sep 2018
01

Overview

Randomised, open-label trial in retained products of conception (RPOC) (2 arms), sponsored by Meir Medical Center. Primary endpoint: Persistent Retained Pregnancy Products Rate at 4 weeks. Status: unknown.

02

Conditions

retained products of conception (RPOC)

Beyond the preview

Go deeper on NCT03230825.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03230825.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call